ZOM Stock Overview
A veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Zomedica Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.13 |
| 52 Week High | US$0.23 |
| 52 Week Low | US$0.12 |
| Beta | 1.06 |
| 11 Month Change | 5.47% |
| 3 Month Change | -2.89% |
| 1 Year Change | -22.37% |
| 33 Year Change | -69.87% |
| 5 Year Change | -63.38% |
| Change since IPO | -84.18% |
Recent News & Updates
Recent updates
Shareholder Returns
| ZOM | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -11.3% | -0.4% | -1.0% |
| 1Y | -22.4% | 20.3% | 30.3% |
Return vs Industry: ZOM underperformed the US Medical Equipment industry which returned 20.3% over the past year.
Return vs Market: ZOM underperformed the US Market which returned 30.3% over the past year.
Price Volatility
| ZOM volatility | |
|---|---|
| ZOM Average Weekly Movement | 7.2% |
| Medical Equipment Industry Average Movement | 8.2% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ZOM has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: ZOM's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 144 | Larry Heaton | www.zomedica.com |
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system. It also provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line of products, including the Assisi Loop, Assisi Loop Lounge, and DentaLoop devices that treat pain and inflammation through delivery of targeted pulsed electromagnetic field focused energy.
Zomedica Corp. Fundamentals Summary
| ZOM fundamental statistics | |
|---|---|
| Market cap | US$123.47m |
| Earnings (TTM) | -US$62.19m |
| Revenue (TTM) | US$26.73m |
4.8x
P/S Ratio-2.1x
P/E RatioIs ZOM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ZOM income statement (TTM) | |
|---|---|
| Revenue | US$26.73m |
| Cost of Revenue | US$8.12m |
| Gross Profit | US$18.61m |
| Other Expenses | US$80.81m |
| Earnings | -US$62.19m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.063 |
| Gross Margin | 69.64% |
| Net Profit Margin | -232.70% |
| Debt/Equity Ratio | 0% |
How did ZOM perform over the long term?
See historical performance and comparison